Cozart/Philips DOA (drugs-of-abuse) test partnership picks up pace
This article was originally published in Clinica
Executive Summary
UK drugs-of-abuse (DOA) testing specialist Cozart has expanded its partnership with Dutch electronics giant Philips, with the signing of a commercialisation agreement for the manufacture and marketing of a new biosensor system.